Sei Investments Co. Has $2.45 Million Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

Sei Investments Co. increased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 260.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 155,010 shares of the company’s stock after purchasing an additional 112,012 shares during the period. Sei Investments Co. owned approximately 0.07% of Oscar Health worth $2,452,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the business. Avalon Trust Co acquired a new position in shares of Oscar Health during the first quarter valued at about $69,000. Quest Partners LLC acquired a new position in Oscar Health during the 2nd quarter worth approximately $93,000. Amalgamated Bank raised its stake in Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares during the period. Farallon Capital Management LLC bought a new position in Oscar Health in the first quarter worth approximately $164,000. Finally, Cornerstone Investment Partners LLC acquired a new stake in Oscar Health in the first quarter valued at approximately $178,000. 75.70% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

OSCR has been the topic of a number of recent research reports. Wells Fargo & Company increased their target price on Oscar Health from $24.00 to $27.00 and gave the stock an “overweight” rating in a report on Wednesday, June 12th. Piper Sandler reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $24.17.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the completion of the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other news, CAO Victoria Baltrus sold 4,226 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at $2,530,257.52. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Mario Schlosser sold 3,198 shares of the company’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $57,532.02. Following the sale, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 169,569 shares of company stock valued at $3,007,069. 25.11% of the stock is owned by insiders.

Oscar Health Stock Performance

Shares of OSCR stock opened at $20.15 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The company has a market cap of $4.78 billion, a P/E ratio of -50.38, a P/E/G ratio of 41.58 and a beta of 1.62. The firm has a 50-day moving average of $18.86 and a 200-day moving average of $17.96. Oscar Health, Inc. has a one year low of $4.72 and a one year high of $23.79.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The business had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.13 billion. During the same period last year, the business posted ($0.07) earnings per share. The business’s revenue for the quarter was up 44.6% on a year-over-year basis. Equities research analysts forecast that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.